• Medical_Professionals
• Medical_students
• Nurses

It is a great pleasure to invite you to be part of the 12th International Congress on SLE, in Melbourne in March 2017, together with the Asian Conference on Autoimmunity. 

In 2017, the world of SLE will be at a crossroads. Advances in technology mean that it is now possible to address virtually any biological target with a specific therapy. Across diseases like rheumatoid arthritis and many cancers, this has meant life-changing and life-saving new therapies. In SLE, progress has been frustratingly slower than that in some other diseases. However, discovery research, translation of discoveries to products, and the ability to successfully evaluate new agents, have accelerated dramatically in recent years, and many lupus researchers and physicians, as well as drug developers and patients, have good reason to believe a ‘new dawn’ is visible at the horizon. 

Autoimmunity is of course the basis of SLE – but also of so many other diseases. Rapid progress in basic and clinical research in autoimmunity has so much to offer the world of SLE.

​

In Melbourne, we will showcase the very best clinical, biological, and translational advances in the field of SLE and autoimmunity. Due to hard work by an expert international organizing committee, this Congress will include an exceptional program focusing on the nexus between laboratory science and clinical translation, include multidisciplinary sessions on topics from B cells to nephritis, and offer a forum for the presentation of new data, including from young investigators who we especially encourage to be part of this congress. In addition, we hope for major collaboration with industry, as it is only by working together that clinicians, academics and industry can achieve their common goal of improving the lives of patients with SLE and autoimmune disease. 

In Melbourne, we are proud to be both Australia’s capital of biomedical research and the world’s most livable city. In a vibrant city based on foundations of arts and science, democracy and tolerance, you will love your visit to Melbourne for its food, European-style café culture, arts and entertainment, and outdoor lifestyle. If you can, I invite you to stay longer in Melbourne and Australia and explore some of the most remarkable cities, and wildernesses, in the world.  

Therefore I most cordially invite you to join us in Melbourne at the 12th International Congress on SLE in 2017, and the Asian Congress on Autoimmunity, and join your colleagues in making a difference.

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Melbourne Convention Exhibition Centre

1 Convention Centre Pl,

South Wharf 3006

Melbourne

www.mcec.com.au​ 

Submission Info

Only abstracts submitted via the online submission form will be sent to the Abstract Review Committee for review.

Abstracts submitted by fax or e-mail will not be accepted.

Please do not submit multiple copies of the same abstract.

The Committee will endeavor to schedule abstracts according to authors' preferences but reserves the right to decide on the final form of presentation.

You will receive a confirmation email upon submitting your abstract. Please contact the Secretariat if you have not received this confirmation email.

All abstracts will be forwarded to the Committee for review. Notifications regarding status will be sent once the review process is complete.

RULES FOR SUBMISSION

All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission. Accepted abstracts won't be proofed by the organizers and will be published in the Congress proceedings exactly as submitted.

The presenting author is expected to attend the Congress and present the poster or oral presentation. Presenting authors of abstracts must be registered participants. Only abstracts of authors, who have paid their registration fees by December 15, 2016 will be scheduled for presentation and included in the LUPUS 2017 and ACA 2017 Final Program.   

The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.

The submitting author is responsible for communication with the Congress Secretariat regarding the abstract. If the submitting author is not the presenting author, it is the submitting author's obligation to update the presenting author on the abstract's status and to ensure the presenting author is registered to the Congress by the above mentioned deadline and is aware of his or her presentation details.

Abstracts must be original and must not be or have been published in a scientific journal prior to LUPUS 2017 & ACA 2017​. However; encore presentations that have been presented at earlier meetings are acceptable.

Abstracts stating "data will be discussed in the presentation" will NOT be accepted.    

GUIDELINES FOR SUBMISSION

Before you begin, please prepare the following information:

Presenting author's contact details

Email address

Full postal address

phone number 

Author and co-authors' details

Full first and family name(s)

Affiliation details: department, institution / hospital, city, state (if relevant), country

Please note that the abstract software is supported by the following browsers: IE 8,9,10 and 11; Chrome (all versions); Firefox and Safari

Abstract title - limited to 25 words in UPPER CASE

Abstract text – limited to 250 words 

Tables – A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract

Graphs and images – A maximum of 3 images can be included per abstract. 

The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG, PNG or GIF format only.

Draft abstracts – The submission form does not allow you to save your abstract as a draft. Only after hitting "Submit" will the abstract information be saved. However, note that you may re-enter the submission system and edit your submitted abstracts any time before the abstract submission deadline of October 19, 2016. 

ABSTRACT SUBMITTERS' DECLARATION  

BEFORE SUBMITTING THE ABSTRACT, THE ABSTRACT SUBMITTER WILL BE REQUIRED TO CONFIRM THE FOLLOWING:

I, the Abstract Submitter, confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.

Submission of the abstract constitutes my consent to publication (e.g. congress website, programmes, other promotions, etc.)

I, the Abstract Submitter, warrant and represent that I am the sole owner or have the rights of all the information and content ("Content") provided to the LUPUS and ACA Congresses and Kenes International (Hereafter: "The Organizers"). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. 

I, the Abstract Submitter, grant the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.

The Organizers reserve the right to remove from any publication an abstract which does not comply with the above.

I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract

LUPUS Congress , Secretariat , Kenes Group

Phone: 011-41-22-908-0488

Email: lupus2017@kenes.com

LUPUS Congress , Secretariat , Kenes Group

Phone: 011-41-22-908-0488

Email: lupus2017@kenes.com